IMMULITE 2000 THYROGLOBULIN L2KTY2

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2012-10-08 for IMMULITE 2000 THYROGLOBULIN L2KTY2 manufactured by Siemens Healthcare Diagnostics.

Event Text Entries

[3040307] Discordant, falsely elevated thyroglobulin (tg) results were obtained on samples from one patient on the immulite 2000 instrument. The discordant result from (b)(6) 2012 was reported to the physician, who questioned the result. The sample was then tested with heterophilic antibodies, which were present. The sample was retested with an alternative method, and the correct result was reported to the physician. The correct result and confirmation of heterophilic antibody presence caused the physician to question prior tg results from that patient. Tg levels had been tested after the patient underwent a total thyroidectomy in september 2008, and several discordant results were obtained between october 2008 and (b)(6) 2012. Siemens received the patient's historic results from 2008 and 2009 on (b)(6) 2012.
Patient Sequence No: 1, Text Type: D, B5


[10211088] The customer called the siemens technical solutions center (tsc) to report the discordant result from (b)(6) 2012. The customer stated that the result did not match the clinical picture, and asked the laboratory to test for heterophilic antibodies. The laboratory discovered that the sample did contain heterophilic antibodies, which were potentially interfering with the tg assay. As per the instructions for use for immulite 2000 thyroglobulin, "heterophilic antibodies in human serum can react with the immunoglobulins included in the assay components causing interference with in vitro immunoassays". The sample was then run with an alternate method of testing, the ultrasensitive elisa, to obtain the correct result. The customer indicated that the correct result and knowledge that heterophilic antibodies were present caused prior tg results from the patient to be questioned. Potentially discordant results were obtained from samples from that patient since october 2008, which contributed to the decision for the patient to have lymph node clearance surgery. The history of results was provided to siemens on (b)(6) 2012. The cause of the discordant results is unknown. Siemens has requested the patient sample for testing. The instrument is performing within specifications. No further evaluation of this issue is required.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2432235-2012-00325
MDR Report Key2776276
Report Source05,06
Date Received2012-10-08
Date of Report2012-05-23
Date of Event2012-05-11
Date Mfgr Received2012-05-23
Date Added to Maude2013-01-23
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMINDY LOSAPIO
Manufacturer Street511 BENEDICT AVENUE
Manufacturer CityTARRYTOWN NY 10591
Manufacturer CountryUS
Manufacturer Postal10591
Manufacturer Phone9145242312
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS
Manufacturer StreetGLYN RHONWY LLANBERIS, CAERNARFON
Manufacturer CityGWYNEDD, WALES LL554EL
Manufacturer CountryUK
Manufacturer Postal CodeLL55 4EL
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameIMMULITE 2000 THYROGLOBULIN
Generic NameIMMULITE 2000
Product CodeMSW
Date Received2012-10-08
Model NumberIMMULITE 2000
Catalog NumberL2KTY2
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS
Manufacturer AddressGLYN RHONWY LLANBERIS, CAERNARFON GWYNEDD, WALES LL554EL UK LL55 4EL


Patients

Patient NumberTreatmentOutcomeDate
10 2012-10-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.